360° SearchNetwork Hot Spots Trends Time Series

Avalide

Type: Product

Name: Avalide

First reported May 17 2013 - Updated May 18 2013 - 1 reports

Bristol Myers: New Drugs Show Promise, Plavix Patent Expiry Still Hurts

As the company reels from the patent expiry of blockbuster drug Plavix, its product pipeline shows promise.Preliminary data from Bristol’s Phase 1 Nivolumab and Yervoy combination study shows that the formulation reduced tumors in the majority of melanoma ... [Published Trefis - May 17 2013]

Entities: Yervoy, Drugs, Plavix, ELIQUIS

First reported Apr 26 2013 - Updated Apr 27 2013 - 2 reports

Bristol-Myers Squibb's New Drugs Can Help Reverse Its Sinking Revenue

Home » Blogs » Bristol Myers Squibb’s (BMY) Q1 results look like a letdown at first glance as the firm reported that its total sales for Q1 2013 were down almost 27% compared to the same quarter last year. However, much of this decline was expected as ... [Published BioPortfolio - Apr 27 2013]

Entities: Bristol-Myers Squibb Company, Avalide, Avapro, Drugs, Plavix

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Bristol net plunges 45 pct. on generic competition

Drugmaker Bristol-Myers Squibb Co. on Thursday posted a 45 percent drop in first-quarter profit as reduced spending and a sharply lower tax rate couldn't make up for plunging sales from increased generic competition to blood thinner Plavix.Revenue from ... [Published Equities.com - Apr 25 2013]

Entities: Bristol-Myers Squibb Company, Avalide, Plavix

First reported Apr 25 2013 - Updated Apr 25 2013 - 4 reports

Bristol Myers Profit Declines on Expired Patents; Matches Earnings Estimates (BMY)

Biopharmaceutical company, Bristol Myers Squibb Co. ( BMY ) saw a decline in earnings on Thursday, caused by the loss of sales from expired patents. Still, the company matched analysts earnings estimates for the first quarter.The New York, NY based company ... [Published Dividend.com - Apr 25 2013]

Entities: Bristol-Myers Squibb Company, Avalide, Avapro

First reported Apr 25 2013 - Updated Apr 25 2013 - 4 reports

Bristol-Myers Squibb Company

UPDATE: Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales

--Bristol-Myers still feeling fallout from lost patent protection on Plavix --"Unremakable quarter" for Bristol-Myers, analyst says--Investors focused on pipeline, including key cancer treatment(Adds stock quote and analyst comment, beginning in paragraph ... [Published Capital.gr - Apr 25 2013]

Entities: Bristol-Myers Squibb Company, Drugs, Plavix

First reported Mar 15 2013 - Updated Mar 15 2013 - 1 reports

Study: Minorities less exposed to some antihypertensives

By Mia Burns A study that was published in the February issue of the American Journal of Hypertension found that blacks, Latinos, and other ethnic minority hypertensive patients who are on dialysis were about 25 percent less likely to have exposure ... [Published Medad Blog - Mar 15 2013]

Entities: Dialysis, Antihypertensive Drug, Avapro, data collection, Hypertension

First reported Feb 17 2013 - Updated Feb 17 2013 - 1 reports

AVALIDE (Irbesartan And Hydrochlorothiazide) Tablet AVALIDE (Irbesartan And Hydrochlorothiazide) Tablet, Film Coated [Bristol-Myers Squibb Company]

Updated Date: Feb 11, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 17 2013]

Entities: Irbesartan, Avalide, Hydrochlorothiazide

First reported Feb 14 2013 - Updated Feb 15 2013 - 1 reports

AVALIDE (Irbesartan And Hydrochlorothiazide) Tablet AVALIDE (Irbesartan And Hydrochlorothiazide) Tablet, Film Coated [Bristol-Myers Squibb Company]

Updated Date: Feb 11, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 14 2013]

Entities: Irbesartan, Avalide, Hydrochlorothiazide

First reported Feb 05 2013 - Updated Feb 05 2013 - 1 reports

AVALIDE (Irbesartan And Hydrochlorothiazide) Tablet [Bryant Ranch Prepack]

Updated Date: Feb 1, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 05 2013]

Entities: Irbesartan, Avalide, Hydrochlorothiazide

First reported Feb 01 2013 - Updated Feb 02 2013 - 2 reports

AVALIDE (Irbesartan And Hydrochlorothiazide) Tablet [Bryant Ranch Prepack]

Updated Date: Feb 1, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 02 2013]

Entities: Irbesartan, Avalide, Hydrochlorothiazide

First reported Jan 16 2013 - Updated Jan 16 2013 - 1 reports

AVALIDE (Irbesartan And Hydrochlorothiazide) Tablet, Film Coated [Sanofi-Aventis U.S. LLC]

Updated Date: Jan 11, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Jan 16 2013]

Entities: Avalide, Irbesartan, Sanofi-aventis US

First reported Jan 11 2013 - Updated Jan 11 2013 - 1 reports

AVALIDE (Irbesartan And Hydrochlorothiazide) Tablet, Film Coated [Sanofi-Aventis U.S. LLC]

Updated Date: Jan 11, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Jan 11 2013]

Entities: Avalide, Irbesartan, Sanofi-aventis US

Quotes

Zacks' analyst wrote, "Bristol-Myers' first quarter 2013 adjusted earnings of $0.41 per share dipped 36% below the year-ago figure. Earnings were hurt primarily by the reduced sales of hypertension treatment Avapro/Avalide and blood-thinner Plavix, which went off-patent in the US in Mar 2012 and May 2012, respectively. Net sales in the quarter declined 27% to $3.8 billion, just shy of the Zacks Consensus Estimate of $3.9 billion. Even though the genericization of Plavix and Avapro has resulted in significant loss of revenues for Bristol-Myers, we believe that its diversified business model combined with its strong financial position will help in countering the headwinds. We maintain our Neutral stance on the stock with a target price of $42.00."

Bristol Myers Squibb Rating Reiterated by Zacks (BMY) [Published American Banking News - Apr 27 2013]

More From BioPortfolio on "Bristol-Myers Squibb's New Drugs Can Help Reverse Its Sinking Revenue"

Bristol-Myers Squibb's New Drugs Can Help Reverse Its Sinking Revenue [Published BioPortfolio - Apr 27 2013]

Bristol shares, up 27% in 2013, slipped 2.5% in early trading Thursday to $40.43. "Overall an unremarkable quarter for BMY, but we think investor focus isn't so much on the numbers, but rather on the pipeline" said Mark Schoenebaum, analyst at ISI Group

UPDATE: Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales [Published Capital.gr - Apr 25 2013]

"The first quarter was a good start to an important year in which our focus will be on the growth of existing brands, the execution of new launches and the continued delivery of a diverse and sustainable pipeline" CEO Lamberto Andreotti said in a statement

Bristol net plunges 45 pct. on generic competition [Published Equities.com - Apr 25 2013]

More Content

sort by: Date \| Relevance
Bristol Myers: New Drugs Show Promise, Plavix P... [Published Trefis - May 17 2013]
Earnings Plummet, Outlook Maintained at Sanofi ... [Published Yahoo! Finance - May 03 2013]
Bristol Myers Squibb Rating Reiterated by Zacks... [Published American Banking News - Apr 27 2013]
Bristol-Myers Squibb's New Drugs Can Help Rever... [Published BioPortfolio - Apr 27 2013]
Bristol-Myers Squibb's New Drugs Can Help Rever... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 26 2013]
Bristol Myers Profit Declines on Expired Patent... [Published Dividend.com - Apr 25 2013]
Bristol-Myers Reports In Line Earnings - Analys... [Published Zacks.com - Apr 25 2013]
UPDATE: Bristol-Myers Profit Drops 45% on Lower... [Published Capital.gr - Apr 25 2013]
Bristol net plunges 45 pct. on generic competition [Published Equities.com - Apr 25 2013]
Bristol-Myers Squibb Profit Plunges On Patent E... [Published RTTNews.com - Apr 25 2013]
Bristol-Myers Q1 Profit Down; Confirms FY13 Pro... [Published RTTNews.com - Apr 25 2013]
Bristol-Myers 1st-Quarter Net Drops 45% on Lowe... [Published Capital.gr - Apr 25 2013]
Bristol-Myers Quarterly Profit Misses Analysts’... [Published Bloomberg - Apr 25 2013]
Bristol-Myers Profit Misses Estimates as New Dr... [Published BusinessWeek - Apr 25 2013]
Study: Minorities less exposed to some antihype... [Published Medad Blog - Mar 15 2013]
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Feb 17 2013]
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Feb 14 2013]
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Feb 05 2013]
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Feb 02 2013]
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Feb 01 2013]
Bristol-Myers Squibb's revenue falls by 23% on ... [Published PharmaBiz - Jan 31 2013]
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Jan 16 2013]
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Jan 11 2013]
Mylan Launches Generic Avapro® Tablets and Gene... [Published PR Newswire - Sep 28 2012]
Q1Medicare.com Drug Search Tools Updated with L... [Published PRWeb - Aug 12 2012]
Fact Sheet for Bristol Myers Squibb Co [Published Able2Act - Jan 02 2008]
Fact Sheet for Bristol Myers Squibb Co [Published Able2Act - Jan 02 2008]

Blogs

sort by: Date \| Relevance
Study: Minorities less exposed to some antihype... [Published Medad Blog - Mar 15 2013] By Mia Burns A study that was published in the February issue of the American Journal of Hypertension found that blacks, Latinos, and other ethnic minority hypertensive patients who are on dialysis were about 25 percent less likely to have exposure ...
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Feb 17 2013] Updated Date: Feb 11, 2013 EST ...
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Feb 14 2013] Updated Date: Feb 11, 2013 EST ...
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Feb 05 2013] Updated Date: Feb 1, 2013 EST ...
AVALIDE (Irbesartan And Hydrochlorothiazide) Ta... [Published DailyMed Drug Label Updates for the last seven ... - Feb 02 2013] Updated Date: Feb 1, 2013 EST ...

Press Releases

sort by: Date \| Relevance
Mylan Launches Generic Avapro® Tablets and Gene... [Published PR Newswire - Sep 28 2012]